Seguimiento de transacciones de insiders en los distintos mercados.
| 30 días | 90 días | 120 días | |
|---|---|---|---|
| Rentabilidad media | 8% | 8.2% | 15.1% |
| Tasa de éxito | 100% | 68% | 82% |
| Transacciones |
1
0% Comprar
|
34
71% Comprar
|
47
69% Comprar
|
| Posición | Compañía | Período |
|---|---|---|
| Chief Executive Officer, Chief Operating Officer, Principal Executive Officer, Director | Paratek Pharmaceuticals Inc | 25 de junio de 2019 - |
| President, Chief Operating Officer, Chief Medical Officer, Director | Paratek Pharmaceuticals Inc | 1 de enero de 2017 - 25 de junio de 2019 |
| Independent Director | Alpine Immune Sciences Inc | None - |
| President, Chief Medical Officer, Director | Paratek Pharmaceuticals Inc | 30 de octubre de 2014 - 1 de enero de 2017 |
Buscar